Resveratrol inhibits the release of soluble fms-like tyrosine kinase (sFlt-1) from human placenta

Melissa J Cudmore, Wenda Ramma, Meng Cai, Takeshi Fujisawa, Shakil Ahmad, Bahjat Al-Ani, Asif Ahmed

Research output: Contribution to journalArticlepeer-review

Abstract

Soluble vascular endothelial growth factor receptor-1 (also know as soluble fms-like tyrosine kinase [sFlt]-1) is a key causative factor of preeclampsia. Resveratrol, a plant phytoalexin, has antiinflammatory and cardioprotective properties. We sought to determine the effect of resveratrol on sFlt-1 release.
Original languageEnglish
Pages (from-to)253.e10-5
JournalAmerican Journal of Obstetrics and Gynecology
Volume206
Issue number3
DOIs
Publication statusPublished - 2012

Fingerprint Dive into the research topics of 'Resveratrol inhibits the release of soluble fms-like tyrosine kinase (sFlt-1) from human placenta'. Together they form a unique fingerprint.

Cite this